N- (4- chlorophenyl)- 3- carboxyamidyl- 5- methylisoxazole

a small-molecule tumour necrosis factor (TNF)-alpha modulator being investigated for its potential in several immune-mediated diseases, including psoriasis; structure in first source

Also Known As:

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Chen, B: 1 article (09/2007)
2.	Holtz, R: 1 article (09/2007)
3.	Huang, W-H: 1 article (09/2007)
4.	Lee, A-R: 1 article (09/2007)
5.	Liu, C: 1 article (09/2007)
6.	Martin, R: 1 article (09/2007)
7.	Shaw, J: 1 article (09/2007)

Related Diseases

1.	Psoriasis (Pustulosis Palmaris et Plantaris) 09/01/2007 - "Our results indicate that UTL-5d may be worthy of further investigation for its potential as a topical agent for psoriasis." 09/01/2007 - "UTL-5d [N-(4-chlorophenyl)-3-carboxyamidyl-5-methylisoxazole] is a small-molecule tumour necrosis factor (TNF)-alpha modulator being investigated for its potential in several immune-mediated diseases, including psoriasis. "
2.	Necrosis 09/01/2007 - "Inhibition of tumour necrosis factor-alpha secretion from EpiDermTM tissues by a novel small molecule, UTL-5d." 09/01/2007 - "UTL-5d [N-(4-chlorophenyl)-3-carboxyamidyl-5-methylisoxazole] is a small-molecule tumour necrosis factor (TNF)-alpha modulator being investigated for its potential in several immune-mediated diseases, including psoriasis. "

Related Drugs and Biologics

1.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)